Send to a Friend Font Size: Increase Decrease

VALN and ASGLY Related Headlines

Jul 29, 2025 10:00AM AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

VALN and ASGLY Related Press Releases

Jul 29, 2025 10:00AM AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

VALN and ASGLY Related SEC Filings